advertisement
Singh IP 9
Showing records 1 to 9 | Display all abstracts from Singh IP96083 Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Singh IP
Clinical Ophthalmology 2021; 15: 3231-3240
95776 Reoperation Rates and Disease Costs for Primary Open-Angle Glaucoma Patients in the United States Treated with Incisional Glaucoma Surgery
Randy Craven E
Ophthalmology. Glaucoma 2022; 5: 297-305
96083 Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Sarkisian S
Clinical Ophthalmology 2021; 15: 3231-3240
95776 Reoperation Rates and Disease Costs for Primary Open-Angle Glaucoma Patients in the United States Treated with Incisional Glaucoma Surgery
Singh IP; Yu TM
Ophthalmology. Glaucoma 2022; 5: 297-305
96083 Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Hornbeak D
Clinical Ophthalmology 2021; 15: 3231-3240
95776 Reoperation Rates and Disease Costs for Primary Open-Angle Glaucoma Patients in the United States Treated with Incisional Glaucoma Surgery
Rhoten S
Ophthalmology. Glaucoma 2022; 5: 297-305
96083 Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Katz LJ; Samuelson T
Clinical Ophthalmology 2021; 15: 3231-3240
95776 Reoperation Rates and Disease Costs for Primary Open-Angle Glaucoma Patients in the United States Treated with Incisional Glaucoma Surgery
Sadruddin OR; Sheybani A
Ophthalmology. Glaucoma 2022; 5: 297-305
96083 Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
Clinical Ophthalmology 2021; 15: 3231-3240
